Global Parkinson’s Disease Treatment Market Report By Drug Class (Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-Inhibitors, Anticholinergics, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212172
May 2020
Report Formats:
The global demand for Parkinson’s Disease Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Parkinson's disease dementia gets developed in the people who are already diagnosed with Parkinson’s Disease Treatment. In Parkinson's disease dementia, thinking and reasoning ability of the patient decreases. Parkinson's disease is a central nervous system disorder in which the nerve cells in the brain get damaged leading to dropping of dopamine levels. Parkinson's disease symptoms include tremors, slow movement, and stiffness, difficulty in walking, shaking and loss of balance. The disease further progresses into depression, dementia and rigidity.
 
Market Dynamics
 
There is no curative treatment available for Parkinson's disease, however symptomatic treatment can be done. The increasing R & D and the latest development in Parkinson's disease dementia treatment is expected to boost the global treatment market. Besides, the increasing geriatric population and increasing cases of Parkinson's disease are the driving forces of the global Parkinson's disease dementia treatment market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of parkinson’s disease treatment.
 
Market Segmentation
 
The entire parkinson’s disease treatment market has been sub-categorized into drug class, distribution channel and patient care setting. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Drug Class
  • Levodopa/carbidopa
  • Dopamine Receptor Agonists
  • MAO-Inhibitors
  • COMT-inhibitors
  • Anticholinergics
  • Other Drugs
 
By Distribution Channel
  • Hospital Pharmacies
  • Retailer Pharmacies
  • Online Pharmacies
 
By Patient Care Setting
  • Hospitals
  • Clinics
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for parkinson’s disease treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Parkinson’s Disease Treatment Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the parkinson’s disease treatment market include Teva, Novartis AG, GSK, AbbVie, Merck, Boehringer Ingelheim, Impax Laboratories, Lundbeck, UCB, Valeant Pharmaceuticals, Acadia, Sun Pharma, Wockhardt, Dr. Reddy’s, Intas, US WorldMeds, Zydus Cadila, Cipla, Strides, 1 A Pharma, Upsher-Smith. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.
 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Parkinson’s Disease Treatment Market
       2.2. Global Parkinson’s Disease Treatment Market Snapshot
 
3 . PARKINSON’S DISEASE TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Parkinson’s Disease Treatment Market
       3.3. Market Restraints of Parkinson’s Disease Treatment Market
       3.4. Opportunities of Parkinson’s Disease Treatment Market
       3.5. Trends of Parkinson’s Disease Treatment Market
       3.6. Porter’s Five Force Analysis of Parkinson’s Disease Treatment Market
       3.7. Parkinson’s Disease Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Class
           3.7.2 Market Attractive Analysis by Distribution Channel
           3.7.3 Market Attractive Analysis by Patient Care Setting
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Parkinson’s Disease Treatment Value Chain Analysis
       4.2. Parkinson’s Disease Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Parkinson’s Disease Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Parkinson’s Disease Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Parkinson’s Disease Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Parkinson’s Disease Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Parkinson’s Disease Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Parkinson’s Disease Treatment Market
 
6 . GLOBAL PARKINSON’S DISEASE TREATMENT MARKET ANALYSIS BY DRUG CLASS
       6.1 Overview by Drug Class
       6.2 Global Parkinson’s Disease Treatment Market Analysis by Drug Class
       6.3 Market Analysis of Levodopa/carbidopa by Regions
       6.4 Market Analysis of Dopamine Receptor Agonists by Regions
       6.6 Market Analysis of MAO-Inhibitors by Regions
       6.5 Market Analysis of COMT-inhibitors by Regions
       6.7 Market Analysis of Anticholinergics by Regions
       6.8 Market Analysis of Other Drugs by Regions
 
7 . GLOBAL PARKINSON’S DISEASE TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Global Parkinson’s Disease Treatment Market Analysis by Distribution Channel
       7.3 Market Analysis of Hospital Pharmacies by Regions
       7.4 Market Analysis of Retailer Pharmacies by Regions
       7.5 Market Analysis of Online Pharmacies by Regions
 
8 . GLOBAL PARKINSON’S DISEASE TREATMENT MARKET ANALYSIS BY PATIENT CARE SETTING
       8.1 Overview by Patient Care Setting
       8.2 Global Parkinson’s Disease Treatment Market Analysis by Patient Care Setting
       8.3 Market Analysis of Hospitals by Regions
       8.4 Market Analysis of Clinics by Regions
 
9 . GLOBAL PARKINSON’S DISEASE TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Parkinson’s Disease Treatment Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Parkinson’s Disease Treatment Market Estimate by Market Segment
           9.4.3. Europe Parkinson’s Disease Treatment Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Parkinson’s Disease Treatment Market Estimate by Market Segment
           9.5.3. Asia Pacific Parkinson’s Disease Treatment Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Parkinson’s Disease Treatment Market Estimate by Market Segment
           9.6.3. Latin America Parkinson’s Disease Treatment Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Parkinson’s Disease Treatment Market Estimate by Market Segment
           9.7.3. Middle East & Africa Parkinson’s Disease Treatment Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa
 
10 . COMPETITIVE LANDSCAPE OF THE PARKINSON’S DISEASE TREATMENT COMPANIES
       10.1. Parkinson’s Disease Treatment Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF PARKINSON’S DISEASE TREATMENT INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Teva
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Novartis AG
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. GSK
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. AbbVie
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Merck
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Boehringer Ingelheim
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Impax Laboratories
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Lundbeck
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. UCB
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Valeant Pharmaceuticals
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Acadia
           11.13.1. Company Overview
           11.13.2. Financials
           11.13.3. Products
           11.13.4. Recent Developments
       11.14. Sun Pharma
           11.14.1. Company Overview
           11.14.2. Financials
           11.14.3. Products
           11.14.4. Recent Developments
       11.15. Wockhardt
           11.15.1. Company Overview
           11.15.2. Financials
           11.15.3. Products
           11.15.4. Recent Developments
       11.16. Dr. Reddy’s
           11.16.1. Company Overview
           11.16.2. Financials
           11.16.3. Products
           11.16.4. Recent Developments
       11.17. Intas
           11.17.1. Company Overview
           11.17.2. Financials
           11.17.3. Products
           11.17.4. Recent Developments
       11.18. US WorldMeds
           11.18.1. Company Overview
           11.18.2. Financials
           11.18.3. Products
           11.18.4. Recent Developments
       11.19. Zydus Cadila
           11.19.1. Company Overview
           11.19.2. Financials
           11.19.3. Products
           11.19.4. Recent Developments
       11.20. Cipla
           11.20.1. Company Overview
           11.20.2. Financials
           11.20.3. Products
           11.20.4. Recent Developments      
        11.21. Strides
           11.21.1. Company Overview
           11.21.2. Financials
           11.21.3. Products
           11.21.4. Recent Developments     
        11.22. 1 A Pharma
           11.22.1. Company Overview
           11.22.2. Financials
           11.22.3. Products
           11.22.4. Recent Developments
       11.23. Upsher-Smith
           11.23.1. Company Overview
           11.23.2. Financials
           11.23.3. Products
           11.23.4. Recent Developments
      
*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Parkinson’s Disease Treatment Market Snapshot
  • Drivers of The Global Parkinson’s Disease Treatment Market Impact Analysis
  • Restraints of The Global Parkinson’s Disease Treatment Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Parkinson’s Disease Treatment Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Parkinson’s Disease Treatment Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Parkinson’s Disease Treatment Market
  • Global Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Levodopa/carbidopa by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Dopamine Receptor Agonists by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in MAO-Inhibitors by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in COMT-inhibitors by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Anticholinergics by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Other Drugs by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis by Distribution Channel (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Retailer Pharmacies by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis by Patient Care Setting (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Hospitals by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Clinics by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market by Geography (USD MN)
  • North America Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • North America Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • North America Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • North America Parkinson’s Disease Treatment Market Estimate by Country (USD MN)
  • United State Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • United State Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • United State Parkinson’s Disease Treatment Market Analysis by Patient Care Setting (USD MN)
  • Rest of North America Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Rest of North America Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of North America Parkinson’s Disease Treatment Market Estimate by Patient Care Setting(USD MN)
  • Europe Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Europe Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Europe Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • United Kingdom Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • United Kingdom Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • France Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • France Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • France Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Germany Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Germany Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Germany Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Rest of Europe Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Rest of Europe Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Asia Pacific Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Asia Pacific Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Asia Pacific Parkinson’s Disease Treatment Market Estimate by Country (USD MN)
  • China Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • China Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • China Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Japan Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Japan Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Japan Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • India Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • India Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • India Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Rest of Asia Pacific Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Rest of Asia Pacific Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Latin America Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Latin America Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Latin America Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Latin America Parkinson’s Disease Treatment Market Estimate by Country (USD MN)
  • Brazil Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Brazil Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Brazil Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Rest of Latin America Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Rest of Latin America Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Middle East & Africa Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Middle East & Africa Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Middle East & Africa Parkinson’s Disease Treatment Market Estimate by Country (USD MN)
  • Middle East Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Middle East Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Middle East Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Africa Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Africa Parkinson’s Disease Treatment Market Estimate by Distribution Channel (USD MN)
  • Africa Parkinson’s Disease Treatment Market Estimate by Patient Care Setting (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES


 
  • Research Scope of Parkinson’s Disease Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Parkinson’s Disease Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Patient Care Setting
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Parkinson’s Disease Treatment Market Analysis by Drug Class (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Levodopa/carbidopa by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Dopamine Receptor Agonists by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in MAO-Inhibitors by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in COMT-inhibitors by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Anticholinergics by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Other Drugs by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis by Distribution Channel (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Retailer Pharmacies by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis by Patient Care Setting (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Hospitals by Geography (USD MN)
  • Global Parkinson’s Disease Treatment Market Analysis in Clinics by Geography (USD MN)
  • Latin America Parkinson’s Disease Treatment Market by Revenue
  • Middle East & Africa Parkinson’s Disease Treatment Market by Revenue
  • Recent Development in Parkinson’s Disease Treatment Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials